Table 2 Patients showing high or low risk for a probiotic-induced sepsis
From: Do children’s upper respiratory tract infections benefit from probiotics?
Type of risk | Patients |
|---|---|
High | Immunocompromised patients |
Premature neonates | |
Low | Patients with a central venous catheter |
Patients receiving probiotics by jejunostomy | |
Patients concomitantly receiving broad spectrum antibiotics to which the probiotic is resistant | |
Patients receiving probiotics with high mucosal adhesion properties or showing an established pathogenicity | |
Patients with cardiac valvular disease (for Lactobacillus probiotics only) |